Patents Assigned to Noema Pharma AG
  • Methods of treatment of tuberous sclerosis complex
    Patent number: 11998535
    Abstract: Provided herein are methods of treating tuberous sclerosis complex in a subject in need thereof by administering to the subject compositions comprising an mGlu5 negative allosteric modulator (NAM), having the structure of Formula I:
    Type: Grant
    Filed: May 11, 2023
    Date of Patent: June 4, 2024
    Assignee: Noema Pharma AG
    Inventor: George Garibaldi
  • Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndrome
    Patent number: 11883385
    Abstract: Provided herein are methods of treating Tourette Syndrome in a subject in need thereof by administering to the subject compositions comprising a PDE10 inhibitor.
    Type: Grant
    Filed: December 2, 2022
    Date of Patent: January 30, 2024
    Assignee: Noema Pharma AG
    Inventor: George Garibaldi
  • Methods of treatment of tuberous sclerosis complex
    Patent number: 11684613
    Abstract: Provided herein are methods of treating tuberous sclerosis complex in a subject in need thereof by administering to the subject compositions comprising an mGlu5 negative allosteric modulator (NAM), having the structure of Formula I:
    Type: Grant
    Filed: December 2, 2022
    Date of Patent: June 27, 2023
    Assignee: Noema Pharma AG
    Inventor: George Garibaldi